Related Experiment Video
Updated: Aug 6, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Dietary FODMAP Manipulation for Exercise-Associated Gastrointestinal Symptoms: Why Symptom Severity Should Guide Our
Rachel Scrivin1,2, Natália Vilela Silva Daniel3, Gary Slater4
1Faculty of Sport and Health, Toi Ohomai Institute of Technology, Tauranga, New Zealand. Rachel.Scrivin@toiohomai.ac.nz.
Abstract:
Exercise-induced gastrointestinal syndrome (EIGS) is a well-defined term that describes disruptions to gastrointestinal integrity and function that occur during exercise. A commonly reported outcome of EIGS is exercise-associated gastrointestinal symptoms (Ex-GIS), including flatulence, lower abdominal bloating and pain, and urge to defecate, which can compromise comfort, training quality and race-day execution. Low-fermentable oligo-, di-, mono-saccharide and polyol (FODMAP) diets are effective at reducing gastrointestinal symptoms in individuals with irritable bowel syndrome and, owing to similarities in symptom presentation, have increasingly been used by athletes to better manage Ex-GIS. This Current Opinion article argues that FODMAP manipulation should be used strategically rather than as a routine dietary default. For athletes with severe Ex-GIS, a short-term low-FODMAP approach may help attenuate symptoms around key training sessions and/or competition. In contrast, athletes with mild or infrequent symptoms may benefit from a more liberal FODMAP intake that mitigates disruptions to gastrointestinal integrity and potentially EIGS outcomes while avoiding unnecessary dietary restriction. However, neither approach has consistently been shown to improve performance. Accordingly, any modification of FODMAP intake should be individualized and guided by likely underlying primary mechanisms, symptom severity, exercise demands, and the need to maintain overall dietary adequacy.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...